CONTEXT: Publication from the analysis of the first 500 patients enrolled in a pulmonary arterial hypertension (PAH) registry showed promising treatment results in stabilising or reducing their 1-year mortality risk Continue Reading
CONTEXT: Publication of an RWE study in type 2 diabetes patients treated with SGLT2 and GLP1- receptor antagonists showing a long term reduction in risk of coronary heart disease | Continue Reading
CONTEXT: Hopefully this report is not the last we will see or hear of the Pistoia Alliance. Bringing the industry together to break down barriers for data sharing on the Continue Reading
CONTEXT: Announcement of a significant piece of research looking at NSCLC across three study types and involving 12,000 patients. This type of big ambition research will no doubt yield significant Continue Reading
CONTEXT: Industry sponsored piece on RWE and RWD – nothing new. IMPACT: Low READ TIME: 1 min Quality Level Mean [1 – 10]: 4 1. “No matter the exit strategy, Continue Reading
CONTEXT: This peer reviewed report on an open label extension to a pivotal ADHD study wouldn’t normally get out attention, but the treatment of kids using digital tech had us Continue Reading
CONTEXT: Peer reviewed article on machine learning (ML) algorithms in an observational schizophrenia study | Dust off your stats textbooks and start googling those ML algorithms to get the most out Continue Reading
CONTEXT: Opinion piece on where the author sees the FDA being focused through this next year. IMPACT: Low READ TIME: 2 mins Quality Level Mean [1 – 10]: 6 1. Continue Reading
CONTEXT: Peer reviewed article form the BMJ describing a retrospective observational study in idiopathic pulmonary fibrosis. IMPACT: Medium READ TIME: 2 mins Quality Level Mean [1 – 10]: 7 1. Continue Reading
CONTEXT: Proposed Modifications to the HIPAA Privacy Rule to Support, and Remove Barriers to, Coordinated Care and Individual Engagement |US Only IMPACT: Low Quality Level Mean [1 – 10]: 5 1. “The proposed Continue Reading
